Title : Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon.

Pub. Date : 2017 Dec 20

PMID : 28986322






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since the SYN-004 drug substance is a buffered liquid, several binder excipients in different ratios were tested to facilitate binding of SYN-004 to sugar spheres. Sugars synemin Homo sapiens